Visual hallucinations in eye disease

Current Opinion in Neurology

Volumn 22, Issue 1, 2009, Pages 28-35

  Ffytche, Dominic H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Charles Bonnet syndrome; Deafferentation; Ophthalmology; Release

Indexed keywords

BEVACIZUMAB; CITALOPRAM; VENLAFAXINE;

AGE DISTRIBUTION; CHARLES BONNET SYNDROME; CLINICAL FEATURE; CONTRAST SENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EYE DISEASE; HUMAN; NEUROPHYSIOLOGY; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCOTOMA; SEX DIFFERENCE; THALAMOCORTICAL TRACT; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY; VISUAL AID; VISUAL HALLUCINATION; VISUAL ILLUSION;

AGE FACTORS; EYE DISEASES; HALLUCINATIONS; HUMANS; PHOTIC STIMULATION; PROGNOSIS; REVIEW LITERATURE AS TOPIC; RISK FACTORS; SYNDROME;

EID: 60449112279     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32831f1b3f     Document Type: Review

References (31)

1. Uhthoff W. Contributions to the visual deceptions (hallucinations, illusions etc) of eye disease. Monatsschrift für Psychiatrie und Neurologie 1899; 5:241-379.
2. ffytche DH. Visual hallucinations and the Charles Bonnet syndrome. Curr Psychiatry Rep 2005; 7:168-179.
3. Tan CS, Lim VS, Ho DY, et al. Charles Bonnet syndrome in Asian patients in a tertiary ophthalmic centre. Br J Ophthalmol 2004; 88:1325-1329.
4. Menon GJ. Complex visual hallucinations in the visually impaired: a structured history-taking approach. Arch Ophthalmol 2005; 123:349-355.
5. Burke W. The neural basis of Charles Bonnet hallucinations: a hypothesis. J Neurol Neurosurg Psychiatry 2002; 73:535-541.
6. Rovner BW. The Charles Bonnet syndrome: a review of recent research. Curr Opin Ophthalmol 2006; 17:275-277.
7. Abbott EJ, Connor GB, Actes PH, Abadi RV. Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet syndrome). Invest Ophthalmol Vis Sci 2007; 48:1416-1423. The only survey of visual hallucinations in AMD to date with a detailed assessment of scotoma size. The review revises risk factors identified in previous studies and questions the use of stringent exclusion criteria.
8. Jackson ML, Bassett K, Nirmalan PV, Sayre EC. Contrast sensitivity and visual hallucinations in patients referred to a low vision rehabilitation clinic. Br J Ophthalmol 2007; 91:296-298. This study suggests that contrast may be a more robust risk factor for visual hallucinations than acuity, which has implications for the design of future studies.
9. Crumbliss KE, Taussig MJ, Jay WM. Vision rehabilitation and Charles Bonnet syndrome. Semin Ophthalmol 2008; 23:121-126.
10. Kinoshita Y, Tsuchiya M, Kawakami N, et al. Hallucinations in visually impaired individuals: an analysis of the National Comorbidity Survey Replication. Soc Psychiatry Psychiatr Epidemiol 2008 [Epub ahead of print].
11. Khan JC, Shahid H, Thurlby DA, et al. Charles Bonnet syndrome in age-related macular degeneration: the nature and frequency of images in subjects with end-stage disease. Ophthalmic Epidemiol 2008; 15:202-208. The largest survey of visual hallucinations in AMD to date. It revises risk factors identified in previous studies and highlights a subgroup with poor prognosis.
12. Holroyd S, Rabins PV, Finkelstein D, et al. Visual hallucinations in patients with macular degeneration. Am J Psychiatry 1992; 149:1701-1706.
13. Crane WG, Fletcher DC, Schuchard RA. Prevalence of photopsias and Charles Bonnet syndrome in a low vision population. Ophthalmol Clin North Am 1994; 7:143-149.
14. Holroyd S, Rabins PV, Finkelstein D, Lavrisha M. Visual hallucinations in patients from an ophthalmology clinic and medical population. J Nerv Ment Dis 1994; 182:273-276.
15. Teunisse RJ, Cruysberg JR, Verbeek AL, Zitman FG. The Charles Bonnet syndrome: a large prospective study in the Netherlands. Br J Psychiatry 1995; 166:254-257.
16. Scott IU, Schein OD, Feuer WJ, Folstein MF. Visual hallucinations in patients with retinal disease. Am J Ophthalmol 2001; 131:590-598.
17. Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol 1990; 300:5-25.
18. Madill SA, ffytche DH. Charles Bonnet syndrome in patients with glaucoma and good acuity. Br J Ophthalmol 2005; 89:785-786; author reply 786.
19. Holroyd S, Rabins PV. A three year follow-up study of visual hallucinations in patients with macular degeneration. J Nerv Ment Dis 1996; 184:188-189.
20. Brown GC, Murphy RP. Visual symptoms associated with choroidal neovascularization. Photopsias and the Charles Bonnet syndrome. Arch Ophthalmol 1992; 110:1251-1256.
21. Levine AM. Visual hallucinations and cataracts. Ophthalmic Surg 1980; 11:95-98.
22. Merabet LB, Maguire D, Warde A, et al. Visual hallucinations during prolonged blindfolding in sighted subjects. J Neuroophthalmol 2004; 24:109-113.
23. ffytche DH. The hodology of hallucinations. Cortex 2008; 44:1067-1083. This study links visual hallucinations in eye disease to burst mode firing in thalamocortical circuits using induced hallucinations in normal sighted individuals.
24. Meyer CH, Mennel S, Horle S, Schmidt JC. Visual hallucinations after intravitreal injection of bevacizumab in vascular age-related macular degeneration. Am J Ophthalmol 2007; 143:169-170. A novel risk factor requiring further study. It is of potential importance because of increasing use of the treatment.
25. Tan CS, Sanjay S, Eong KG. Charles Bonnet syndrome (visual hallucinations) after intravitreal avastin injection for age-related macular degeneration. Am J Ophthalmol 2007; 144:330; author reply 330-331.
26. Wagle AM, Au Eong KG. Transient formed visual hallucinations following macular hole surgery. Eye 2007; 21:106-107.
27. Lang UE, Stogowski D, Schulze D, et al. Charles Bonnet syndrome: success-ful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors. J Psychopharmacol 2007; 21:553-555. Potentially important report highlighting the possible therapeutic effect of a drug class previously untested in the context of visual hallucinations but theoretically linked to them.
28. ffytche DH. Visual hallucinatory syndromes: past, present, and future. Dialogues Clin Neurosci 2007; 9:173-189. A history of the Charles Bonnet syndrome emphasising different uses of the term.
29. Bartlet JEA. A case of organized visual hallucinations in an old man with cataract and their relation to the phenomena of the phantom limb. Brain 1951; 74:363-373.
30. Hedges TR Jr. Charles Bonnet, his life, and his syndrome. Surv Ophthalmol 2007; 52:111-114. A biography of Charles Bonnet aimed at clinicians, with translated excerpts of key passages related to visual hallucinations.
31. Tan CS, Au Eong KG. Visual hallucinations in an elderly woman: was it really Charles Bonnet syndrome? J Am Geriatr Soc 2007; 55:144-145; author reply 145.